Wall Street Bets Lilly’s GLP-1 Portfolio, Missed $1T
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Looking to earn money today without a traditional job? Discover various options that can help you start making money quickly and easily.
24,126 articlesInvestors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Amazon unveils a $25 billion bond tranche to accelerate AWS growth and custom silicon, highlighting a silicon-first p...
Two popular India ETFs offer distinct bets on growth and profitability. This analysis breaks down structure, performa...
Micron unveils a historic plan to expand memory fabrication in the United States, led by CEO Sanjay Mehrotra. The mov...
Johnson & Johnson and Coca-Cola posted strong Q1 2026 results as markets rotate toward defensive plays. The big quest...
June inflation fell as energy and shelter costs cooled, pushing traders to delay expectations of a near-term Fed rate...
Two giants in chip-design software compete for your next tech stock buy. This guide breaks down Cadence Design System...
Lucid stock bounces back after a dramatic drop fueled by rumors. This guide explains what drove the move, what it mea...
Sen. JD Vance faulted the Trump administration's handling of Epstein-related documents, calling out missteps in commu...
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Oracle just fresh 52-week lows as a credit downgrade highlights the tension between expensive AI infrastructure and c...
A disciplined approach using SPYI could deliver about $100 in monthly cash from a $10,000 investment, driven by optio...